All In Biotech

Drug Trial Radar · NCT05254366

A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice

A Domestic, Prospective, Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice

Last checked: Nov 20, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

2,022

Actual

Start

Jan 30, 2022

Primary completion

Feb 8, 2023

Study completion Feb 8, 2023

Sponsor

Sponsor type
Industry
First posted
Feb 24, 2022

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a non-interventional study of remazolam toluenesulfonate (rebenin ®) for injection in Chinese patients. A total of 2000 patients were enrolled in this study based on the preliminary safety assessment of rebenin ®, and all safety information was obtained

Conditions

  • Gastroscopic and Colonoscopic Sedation

Interventions

  • Remimazolam Tosilate for InjectionDrug

    Remimazolam Tosilate for Injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse eventsTime frame: Within 3 days of receiving gastroscopy and colonoscopy

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • The People's Hospital of Chizhou

    Chizhou, Anhui, China

  • First Affiliated Hospital of Shantou University Medical College

    Shantou, Guangdong, China

  • Shenzhen People's Hospital

    Shenzhen, Guangdong, China

  • Shengli Oilfield Central Hospital

    Dongying, Guangxi, China

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China

  • Wuhan Central Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • Zhongnan Hospital of Wuhan University

    Wuhan, Hubei, China

  • Hunan Provincial People's Hospital and The First Affiliated Hospital of Hunan Normal University

    Changsha, Hunan, China

  • Changshu No.2 People's Hospital (Affiliated Changshu Hospital of Nantong University)

    Changshu, Jiangsu, China

  • Suqian People's Hospital of Nanjing Drum Tower Hospital Group

    Suqian, Jiangsu, China

  • Zhangjiagang First People's Hospital

    Suzhou, Jiangsu, China

  • Binzhou Medical University Hospital

    Binzhou, Shandong, China

  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine

    Jinan, Shandong, China

  • Linyi People's Hospital

    Linyi, Shandong, China

  • Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China

  • Dazhou Central Hospital

    Dazhou, Sichaun, China

  • Leshan People's Hospital

    Leshan, Sichuan, China

  • Tianjin Nankai Hospital, Tianjin Medical University

    Tianjin, Tianjin Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.